Immunohistochemical and molecular detection of equine herpesvirus 1 in Uruguay by Easton, C. et al.
Rev. sci. tech. Off. int. Epiz., 2009, 28 (3), 1085-1090
Immunohistochemical and molecular detection 
of equine herpesvirus 1 in Uruguay
C. Eastonfl), N.A. Fuentealbaa4), C. Paullierfl), P. Alonzo(l), J. Carluccio,2) 
&C.M. Galosi '3'5>*
(1) Department of Pathobiology, Veterinary Laboratories Division (DILAVE) 'Miguel C. Rubino', General 
Direction of Livestock Services of the Ministry of Livestock, Agriculture and Fisheries (MGAP). Ruta 8 Brig. 
Grab JA Lavalleja, Km.17.500, Montevideo, Uruguay
(2) Department of Equine Clinic, Faculty of Veterinary Medicine, University of the Republic, A Lasplaces 1550, 
Montevideo, Uruguay
(3) Department of Virology, Faculty of Veterinary Sciences, National University of La Plata, 60 y 118, CC296, 
1900 La Plata, Buenos Aires, Argentina
(4) National Research Council (CONICET), Av. Rivadavia 1917, C1033 AAJ, Buenos Aires, Argentina
(5) Scientific Research Commission (CIC), 10 y 526,1900 La Plata, Buenos Aires, Argentina
"Corresponding author: cmgalosi@fcv.unlp.edu.ar; cmgalosi@yahoo.com
Submitted for publication: 24 July 2008 
Accepted for publication: 7 May 2009
Summary
Equine herpesvirus 1 (EHV-1) is a major cause of epidemic abortion, neonatal 
mortality, respiratory disease and neurological disorders in horses. In South 
America, the virus has been isolated in Brazil, Argentina and Colombia. In Chile 
pathological findings from one aborted foetus have been reported, and in 
Uruguay only serological data about EHV-1 activity have been found. Some 
pathological findings were reported in Uruguay several years ago, but these data 
have never been officially confirmed. The present work describes the relevant 
findings of a study of EHV-1 infections in the Uruguayan equine population using 
polymerase chain reaction (PCR) and histological and immunohistochemical 
analysis techniques. The sequence analysis of a portion of the glycoprotein C 
gene amplified by PCR confirmed EHV-1 activity. The real-time PCR revealed the 
association of the virus with the non-neuropathogenic genotype. This study 
describes for the first time the immunohistochemical and molecular detection of 
EHV-1 in Uruguay.
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Introduction
Equine herpesvirus 1 (EHV-1) is a major cause of epidemic 
abortion, neonatal mortality, respiratory disease and 
neurological disorders in horses. Infection by this virus is a 
serious economic problem in the horse industry 
worldwide, especially on breeding farms (3, 6, 11). The 
severity of the disease resulting from EHV-1 infection is 
likely to be influenced by a number of factors, including 
the age and physical condition of the host, whether the 
infection is primary, secondary or a reactivation of a latent 
virus, the immune status of the host and the virulence of 
the strain involved. Recent experimental studies have 
identified a single nucleotide polymorphism (A225-/G2254) 
within the EHV-1 gene encoding the viral 
deoxyribonucleic acid (DNA) polymerase (open reading 
frame-30 [ORF-30]) that is highly associated with the viral 
attribute of neuropathogenicity in horses (10). The 
pathogenesis of abortion induced by this virus is still not 
fully understood. After airborne infection, the virus 
replicates in the nasal mucosa and via infected 
mononuclear leucocytes it reaches various organs, 
including the endometrium. Severe infarction of the 
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endometrium produced by vasculitis and thrombi may 
lead to detachment of the placenta and abortion, even 
before the virus reaches the foetus. In cases with milder 
and circumscribed lesions, infarction causes only slight 
tissue damage, the abortion is not immediately produced, 
the virus reaches the foetus via the circulation and the 
aborted foetus is virologically positive (16).
In South America, the first isolates from an equine foetus 
aborted due to EHV-1 were reported in Brazil and 
Argentina in 1966 and 1979 respectively (7, 9). Chile 
reported pathological lesions in an aborted foetus in 
1998 (13) and Peru and Paraguay reported the presence of 
respiratory clinical signs and abortions in 2001, although 
these data were not officially declared. In addition, the 
virus has been isolated in Venezuela (2001) and Colombia 
(2002) (5, 14).
In Uruguay, only sporadic serological data about 
EHV-1 activity have been reported (4). The virus has not 
yet been isolated and information on the pathological 
findings was found several years ago but not published. In 
addition, neurological disease associated with EHV-1 has 
never been reported. However, the immunisation of horses 
on some farms has been implemented with an inactivated 
vaccine.
Routine diagnostic methods to confirm EHV-1 infection 
are virus isolation (VI) and direct immunofluorescence, 
which detects viral antigens in fresh foetal tissues. 
Immunohistochemical (IHC) methods to detect antigens in 
formalin-fixed tissues and polymerase chain reaction 
(PCR) have been useful in diagnostic laboratory settings 
(12, 14). In addition, Allen has developed a real-time 
PCR for rapid diagnosis of neuropathogenic strains (1).
This study describes, for the first time, the confirmatory 
pathological, immunohistochemical and molecular 
findings about EHV-1 activity among horses in Uruguay.
Materials and methods
Samples
Samples were taken from a case of equine abortion of 
a nine-month-old foetus that arrived at the Laboratory of 
the Department of Pathobiology, Veterinary Laboratories 
Division ‘M.C. Rubino’, Montevideo, LIruguay. According 
to standard procedures, necropsy was carried out and 
samples were taken from the lung, liver, kidney, spleen, 
heart, central nervous system, thymus and placenta. All the 
samples were directly fixed by immersion in 10% neutral 
buffered formalin (pH 7.2 to pH 7.4) for 72 h and 
embedded in paraffin wax at 56°C to 59°C.
Histological and immunocytochemical analysis
Sections of 5 pm of paraffin-embedded tissues were stained 
with haematoxylin and eosin. Some sections of liver and 
lungs were processed for IHC analysis. The slides were 
deparaffinised by immersion in xylene and rehydrated with 
graded alcohols. After blocking endogenous peroxidase 
activities with 1% H2O2 in methanol, non-specific 
background staining was reduced by covering the 
tissue sections with two alternative blocking solutions: 
skim milk (1% to 5%) in phosphate-buffered saline (PBS) 
or bovine serum albumin (0.5% or 1%) in PBS. The 
sections were then washed with PBS, incubated for 30 min 
with 1:2000 monoclonal antibody (Ab) specific to 
EHV-1 (supplied by Dr Makamoto Haritani, National 
Institute of Animal Health, Tsukuba, Japan) and 
revealed with a commercial kit (DakoCytomation LSAB 2 
Systems, DakoCytomation, Carpinteria, CA 93013, LInited 
States of America [LISA]). The slides were then 
counterstained with aqueous haematoxylin. Negative 
controls (liver and lungs from a healthy, EHV-l-free horse) 
were included.
Polymerase chain reaction
Sections of 5 pm were deparaffinised in a tube by 
immersion in xylene at 37°C for 30 min and then 
centrifuged at 3,000 g. The same procedure was repeated 
with 100% and 95% ethanol. Pellets of samples were 
digested for 3 h at 50°C in TEN buffer (1 M Tris, 
0.05 M ethylenediaminetetra-acetic acid and 0.3 M sodium 
chloride) containing 10% sodium dodecyl sulphate and 
0.1 mg of proteinase K/ml. Then, 1 ml of 6 M sodium 
chloride was added and, after shaking, ethanol 
precipitation was carried out. Total DNAs were suspended 
in distilled water. At the first step, the amplification was 
performed according to published methods and using a 
pair of specific oligonucleotide primers derived from the 
EHV-1 glycoprotein C gene region (8). Deoxyribonucleic 
acid from EHV-1 and EHV-4 was used as a control. The 
PCR products were purified using a gel extraction kit 
(Wizard® SV Gel and PCR Clean Lip, Promega) and 
sequenced (Biotechnology Resource Center, LIniversity of 
Cornell, Ithaca, LISA). The sequences were analysed and 
compared with the homologous sequence from the EHV-1 
reference Ab4 strain (GenBank, access number AY665713) 
using Clustal X version 1.92 software.
At the second step, a real-time PCR was performed 
according to the methodology previously described by 
Allen and using specific primers that amplify a 145 base 
pair (bp) fragment of the ORF-30 of EHV-1 (1). The 
reaction was carried out by researchers of the National 
Institute of Agricultural Technology (INTA, Castelar, 
Buenos Aires Province, Argentina) using an ABI 7500 Fast 
Real-Time PCR system (Applied Biosystems, Foster City, 
CA, USA).
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Results
Histological examination of the lungs revealed 
disseminated foci of fibrinous alveolar exudates with foci 
of necrosis in the bronchiolar epithelium associated with 
intranuclear inclusion bodies (IC) as well as cell infiltration 
into the lung parenchyma. The liver showed multifocal 
hepatocellular necrosis and degeneration, with moderate 
infiltration by macrophages. A few IC were seen in the 
hepatocytes and Kupffer cells around the necrotic areas. 
No lesions were observed in the other samples studied. A 
positive staining reaction indicated binding of Ab to sites 
of the EHV-1 antigen, producing a deep-brown colour 
which contrasted sharply with the blue counterstain of the 
tissues. This positive IHC stain was observed associated 
with necrotic foci in the liver (Fig. 1), as well as with the 
broncho-alveolar epithelial cells and alveolar macrophages 
of the lungs (Fig. 2). No non-specific brown staining was 
observed when 5% skim milk in PBS or 1% bovine serum
Fig. 1
Equine foetal liver infected with equine herpesvirus 1
Necrotic focus with positive reaction (immunohistochemistry 400 x)
Equine foetal lung infected with equine herpesvirus 1
Bronchiolar epithelium and alveolar macrophages with positive reaction 
(immunohistochemistry 1000 x)
albumin in PBS was used. A 489 489-bp band amplified by 
direct PCR was observed from samples prepared from lung 
and liver tissues. No amplification was detected for EHV-4 
under the conditions described here (Fig. 3). Both 
sequences analysed showed identity with the 
corresponding sequence of the EHV-1 reference Ab4 strain. 
Real-time PCR revealed association of the virus with the 
non-neuropathogenic genotype (A2254).
Discussion
For the diagnosis of EHV-1 infection associated with 
abortion in mares, conventional VI is often considered the 
‘gold standard’ technique (16). Virus isolation is highly 
sensitive, but the technique requires highly trained 
technicians to perform the test, and it can take several 
days, or sometimes weeks, to complete. Moreover, the 
samples for VI need to be maintained at an optimal 
temperature. In this study, the samples could not be 
processed for VI.
The IHC test is a sensitive, specific test for EHV-1, but has 
not always given 100% correlation with VI results (15). 
However, in the present work pathological changes and 
IHC analysis showed with certainty the presence of the 
antigen in tissues from the aborted foetus.
M 1 2 3 4 M
Fig. 3
Electrophoresis of polymerase chain reaction products from 
lung and liver foetal tissues amplified with primer pair specific 
for equine herpesvirus 1 glycoprotein C
The number on the right denotes the number
of base pairs (bp) for positive amplification
Lane M: molecular weight markers (100 bp to 1500 bp)
Lane 1: positive control (DNA of Japanese HH1 
reference strain of EHV-1)
Lane 2: negative control (DNA of Japanese TH20
reference strain of EHV-4)
Lanes 3 and 4: positive amplification from lung and liver, respectively
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Direct PCR was a valuable and powerful adjunct to confirm 
EHV-1 diagnosis. In addition, the sequence of a portion of 
the glycoprotein C gene amplified by PCR confirmed 
EHV-1 activity Furthermore, real-time PCR reaffirmed the 
first result and revealed that the strain was not associated 
with the neuropathogenic genotype (G225-j)-
Reports of EHV-1 neurological disease have been 
increasing in frequency and severity, particularly in recent 
years in the FISA and Europe (2). Countries of South 
America that have reported EHV-1 activity among their 
equine populations have reported only respiratory disease 
and abortion; there are no references to neurological 
disease caused by EHV-1. Only recent research carried out 
in Colombia into EHV-1 DNA detection in peripheral 
blood mononuclear cells by PCR, and the subsequent 
study of the gene sequence that encodes the viral DNA 
polymerase, showed that the circulating amplified viral 
strain was not neuropathogenic (14).
Recent studies in Argentina by real-time PCR have revealed 
that 7% of the strains isolated in the country between 1996 
and 2008 from cases of abortions and neurological disease 
were associated with the neuropathogenic genotype 
(G225-j) (data not yet published). This is a very important 
finding because the main equine activity is in Buenos Aires 
province, geographically very close to Uruguay. This is a 
relevant epidemiological situation that emphasises the 
need to isolate the virus from Uruguayan equines and to 
know which EHV-1 genotypes are circulating. On the other 
hand, although the virus has not been isolated yet, it is 
important to regularly re-vaccinate pregnant mares and 
other horses on breeding farms to reduce the potential risk 
of abortion storm and neurological disease.
The results presented here constitute the first official report 
of abortion produced by EHV-1 among horses from the 
Uruguayan equine population.
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Détection immunohistochimique et caractérisation 
moléculaire de l'herpèsvirus équin de type 1 en Uruguay
C. Easton, N.A. Fuentealba, C. Pauli1er, P. Alonzo, J. Carlucclo & 
C.M. Galosl
Résumé
L'herpèsvirus équin de type 1 (EHV-1) est un virus important qui provoque chez 
le cheval des avortements infectieux, une mortalité néonatale, des pathologies 
respiratoires et des troubles neurologiques. En Amérique du Sud, le virus a été 
isolé au Brésil, en Argentine et en Colombie. Au Chili, des lésions pathologiques 
ont été signalées chez un foetus avorté ; en Uruguay, l'activité du virus EHV-1 
n'avait été jusqu'à présent décelée que lors d'analyses sérologiques. Il y a 
quelques années, des cas de lésions ont bien été signalés mais n'ont jamais été 
officiellement confirmés. Les auteurs décrivent les résultats d'une étude sur 
l'infection par le virus EHV-1 dans la population équine d'Uruguay, basée sur la 
technique d'amplification en chaîne par polymérase (PCR) et sur des analyses 
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histologiques et immunohistochimiques. L'analyse de séquence d'un fragment 
du gène de la glycoprotéine C amplifié par PCR a confirmé l'activité du virus 
EHV-1. L'amplification par PCR en temps réel a révélé que la souche virale 
appartenait au génotype non neuropathogénique. Il s'agit de la première 
détection immunohistochimique et moléculaire du virus EHV-1 en Uruguay.
Mots-clés
Caractérisation moléculaire - Détection moléculaire - Herpèsvlrus équin de type 1 - 
Immunohistochimie - Tissus de fœtus - Uruguay.
Detección inmunohistoquímica y molecular 
del herpesvirus equino 1 en el Uruguay
C. Easton, N.A. Fuentealba, C. Paullier, P. Alonzo, J. Carluccio
& C.M. Galosi
Resumen
El herpesvirus equino 1 (EHV-1) es una de las principales causas de aborto 
epidémico, mortalidad neonatal, enfermedad respiratoria y trastornos 
neurológicos en el caballo. En Sudamérica, este virus ha sido aislado en Brasil, 
Argentina y Colombia. En Chile se han descripto signos patológicos en un feto 
abortado, y en el Uruguay sólo se han comunicado datos serológicas que 
revelan la actividad del EHV-1. Hace varios años se describieron en el Uruguay 
signos patológicos, aunque ello nunca fue confirmado oficialmente. En este 
trabajo se describen las conclusiones obtenidas de un estudio sobre infección 
por EHV-1 en la población equina uruguaya, para el cual se utilizó la reacción en 
cadena de la polimerasa (PCR) y técnicas de análisis histológico e 
inmunohistoquímico. El análisis de la secuencia de un fragmento del gen de la 
glicoproteína C amplificado por PCR confirmó la existencia de actividad del 
EHV-1. La PCR en tiempo real corroboró la asociación del virus con el genotipo 
no neuropatógeno. Este estudio describe la primera detección molecular e 
inmunohistoquímica del EHV-1 realizada en el Uruguay.
Palabras clave
Caracterización molecular - Detección molecular - Herpesvirus equino 1 - 
Inmunohistoquímica - Tejidos fetales - Uruguay.
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